2019 Q1 Form 10-Q Financial Statement
#000156459019017983 Filed on May 09, 2019
Income Statement
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| YoY Change | ||
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $2.760M | $1.770M |
| YoY Change | 55.93% | 1.72% |
| % of Gross Profit | ||
| Research & Development | $1.400M | $8.540M |
| YoY Change | -83.61% | 189.49% |
| % of Gross Profit | ||
| Depreciation & Amortization | $307.0K | $107.0K |
| YoY Change | 186.92% | 18.89% |
| % of Gross Profit | ||
| Operating Expenses | $1.400M | $10.42M |
| YoY Change | -86.56% | 79.93% |
| Operating Profit | -$12.92M | -$32.11M |
| YoY Change | -59.76% | 572.54% |
| Interest Expense | -$20.00K | -$104.0K |
| YoY Change | -80.77% | -158.43% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $960.0K | -$221.0K |
| YoY Change | -534.39% | -49.43% |
| Pretax Income | -$12.11M | -$31.40M |
| YoY Change | -61.43% | 502.65% |
| Income Tax | $0.00 | -$4.555M |
| % Of Pretax Income | ||
| Net Earnings | -$12.11M | -$26.85M |
| YoY Change | -54.89% | 439.79% |
| Net Earnings / Revenue | ||
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$336.2K | -$857.3K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 35.34M | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $105.2M | $85.00M |
| YoY Change | 23.76% | 989.74% |
| Cash & Equivalents | $25.67M | $22.12M |
| Short-Term Investments | $79.50M | $62.90M |
| Other Short-Term Assets | $800.0K | $1.600M |
| YoY Change | -50.0% | 300.0% |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $107.5M | $87.60M |
| YoY Change | 22.72% | 968.29% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $1.700M | $800.0K |
| YoY Change | 112.5% | 700.0% |
| Goodwill | $26.80M | |
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $1.100M | $1.100M |
| YoY Change | 0.0% | 1000.0% |
| Total Long-Term Assets | $40.80M | $41.30M |
| YoY Change | -1.21% | 624.56% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $107.5M | $87.60M |
| Total Long-Term Assets | $40.80M | $41.30M |
| Total Assets | $148.3M | $128.9M |
| YoY Change | 15.05% | 827.34% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $3.500M | $3.400M |
| YoY Change | 2.94% | 580.0% |
| Accrued Expenses | $5.100M | $1.900M |
| YoY Change | 168.42% | -57.78% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $0.00 | |
| YoY Change | -100.0% | |
| Total Short-Term Liabilities | $8.900M | $5.400M |
| YoY Change | 64.81% | -18.18% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $24.70M | $15.20M |
| YoY Change | 62.5% | 700.0% |
| Other Long-Term Liabilities | $12.90M | $11.90M |
| YoY Change | 8.4% | |
| Total Long-Term Liabilities | $37.60M | $27.10M |
| YoY Change | 38.75% | 1326.32% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $8.900M | $5.400M |
| Total Long-Term Liabilities | $37.60M | $27.10M |
| Total Liabilities | $46.50M | $35.20M |
| YoY Change | 32.1% | 270.53% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $101.8M | $93.70M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $148.3M | $128.9M |
| YoY Change | 15.05% | 827.34% |
Cashflow Statement
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$12.11M | -$26.85M |
| YoY Change | -54.89% | 439.79% |
| Depreciation, Depletion And Amortization | $307.0K | $107.0K |
| YoY Change | 186.92% | 18.89% |
| Cash From Operating Activities | -$10.86M | -$9.671M |
| YoY Change | 12.28% | 240.53% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $96.00K | $19.00K |
| YoY Change | 405.26% | -67.8% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $7.420M | $9.410M |
| YoY Change | -21.15% | |
| Cash From Investing Activities | $7.320M | $9.390M |
| YoY Change | -22.04% | -15750.0% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $4.890M | $493.0K |
| YoY Change | 891.89% | |
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 4.896M | 271.0K |
| YoY Change | 1706.64% | |
| NET CHANGE | ||
| Cash From Operating Activities | -10.86M | -9.671M |
| Cash From Investing Activities | 7.320M | 9.390M |
| Cash From Financing Activities | 4.896M | 271.0K |
| Net Change In Cash | 1.370M | 1.000K |
| YoY Change | 136900.0% | -100.03% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$10.86M | -$9.671M |
| Capital Expenditures | $96.00K | $19.00K |
| Free Cash Flow | -$10.96M | -$9.690M |
| YoY Change | 13.05% | 234.25% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q1 | us-gaap |
Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
|
515000 | |
| CY2018Q4 | us-gaap |
Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
|
70000 | |
| CY2018Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-26532000 | |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12112000 | |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-26849000 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.34 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.86 | |
| CY2018Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-61000 | |
| CY2019Q1 | svra |
Tax Credit Income
TaxCreditIncome
|
964000 | |
| CY2018Q1 | svra |
Tax Credit Income
TaxCreditIncome
|
924000 | |
| CY2019Q1 | svra |
Change In Fair Value Of Financial Instruments Net Of Contingent Consideration
ChangeInFairValueOfFinancialInstrumentsNetOfContingentConsideration
|
-77000 | |
| CY2018Q1 | svra |
Change In Fair Value Of Financial Instruments Net Of Contingent Consideration
ChangeInFairValueOfFinancialInstrumentsNetOfContingentConsideration
|
-56000 | |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
36016406 | |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
31318746 | |
| CY2019Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-12112000 | |
| CY2018Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-31404000 | |
| CY2018Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-4555000 | |
| CY2019Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2763000 | |
| CY2018Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1769000 | |
| CY2018Q1 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
21692000 | |
| CY2019Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-20000 | |
| CY2018Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-104000 | |
| CY2019Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-59000 | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-225000 | |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
341000 | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
26000 | |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-24000 | |
| CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-12311000 | |
| CY2019Q1 | svra |
Issuance Of Common Stock Upon At The Market Offering Net
IssuanceOfCommonStockUponAtTheMarketOfferingNet
|
4890000 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
6000 | |
| CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1000000 | |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
119309000 | |
| CY2018Q1 | svra |
Issuance Of Common Stock Upon At The Market Offering Net
IssuanceOfCommonStockUponAtTheMarketOfferingNet
|
493000 | |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
3000 | |
| CY2018Q1 | svra |
Issuance Of Common Stock Upon Exercise Of Warrants Amount
IssuanceOfCommonStockUponExerciseOfWarrantsAmount
|
18000 | |
| CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
412000 | |
| CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
93703000 | |
| CY2019Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-12112000 | |
| CY2018Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-26849000 | |
| CY2019Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
307000 | |
| CY2018Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
107000 | |
| CY2019Q1 | svra |
Change In Fair Value Of Financial Instruments
ChangeInFairValueOfFinancialInstruments
|
-77000 | |
| CY2018Q1 | svra |
Change In Fair Value Of Financial Instruments
ChangeInFairValueOfFinancialInstruments
|
-96000 | |
| CY2019Q1 | svra |
Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
|
133000 | |
| CY2018Q1 | svra |
Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
|
-134000 | |
| CY2019Q1 | svra |
Paid In Kind Interest Income Expense
PaidInKindInterestIncomeExpense
|
-4000 | |
| CY2018Q1 | svra |
Paid In Kind Interest Income Expense
PaidInKindInterestIncomeExpense
|
35000 | |
| CY2019Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
147000 | |
| CY2018Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
109000 | |
| CY2019Q1 | svra |
Accretion On Discount To Short Term Investments
AccretionOnDiscountToShortTermInvestments
|
342000 | |
| CY2018Q1 | svra |
Accretion On Discount To Short Term Investments
AccretionOnDiscountToShortTermInvestments
|
138000 | |
| CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1000000 | |
| CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
412000 | |
| CY2018Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-4555000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-69000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-54000 | |
| CY2019Q1 | svra |
Increase Decrease In Noncurrent Assets
IncreaseDecreaseInNoncurrentAssets
|
953000 | |
| CY2019Q1 | svra |
Increase Decrease In Accounts Payable And Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
|
953000 | |
| CY2018Q1 | svra |
Increase Decrease In Accounts Payable And Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
|
-554000 | |
| CY2019Q1 | svra |
Increase Decrease In Long Term Liabilities
IncreaseDecreaseInLongTermLiabilities
|
-193000 | |
| CY2018Q1 | svra |
Increase Decrease In Long Term Liabilities
IncreaseDecreaseInLongTermLiabilities
|
-7000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10859000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9671000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
96000 | |
| CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
19000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
46035000 | |
| CY2018Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
15891000 | |
| CY2019Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
42800000 | |
| CY2018Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
25300000 | |
| CY2019Q1 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
10651000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
7320000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
9390000 | |
| CY2018Q1 | svra |
Proceeds From Issuance Of Common Stock Upon Exercise Of Warrants
ProceedsFromIssuanceOfCommonStockUponExerciseOfWarrants
|
18000 | |
| CY2019Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4890000 | |
| CY2018Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
493000 | |
| CY2019Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
6000 | |
| CY2018Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
3000 | |
| CY2018Q1 | us-gaap |
Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
|
243000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4896000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
271000 | |
| CY2019Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
13000 | |
| CY2018Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
11000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1370000 | |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1000 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
24301000 | |
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
22121000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
25671000 | |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
22122000 | |
| CY2019Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
528000 | |
| CY2018Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
334000 | |
| CY2019Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management’s estimates include those related to the accrual of research and development costs, certain financial instruments recorded at fair value, stock-based compensation, contingent consideration, and the valuation allowance for deferred tax assets. The Company bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Accordingly, actual results could be materially different from those estimates. </p> | |
| CY2019Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents and foreign exchange derivatives not designated as hedging. The Company places its cash and cash equivalents with a limited number of high-quality financial institutions and at times may exceed the amount of insurance provided on such deposits. </p> | |
| CY2019Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
| CY2019Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
0 | |
| CY2019Q1 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
us-gaap:ProductMember | |
| CY2019Q1 | svra |
Liquid Investments Maturity Period
LiquidInvestmentsMaturityPeriod
|
three months or less | |
| CY2019Q1 | us-gaap |
Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
|
-100000 | |
| CY2019Q1 | svra |
In Process Research And Development Decrease
InProcessResearchAndDevelopmentDecrease
|
200000 | |
| CY2019Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1400000 | |
| CY2019Q1 | svra |
Date Of Agreement
DateOfAgreement
|
2018-10-08 | |
| CY2019Q1 | us-gaap |
Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
|
12535000 | |
| CY2019Q1 | svra |
Contingent Milestones Or Co Development Commitments Incurred
ContingentMilestonesOrCoDevelopmentCommitmentsIncurred
|
0 | |
| CY2019Q1 | svra |
Contingent Milestones Or Co Development Commitments Remunerated
ContingentMilestonesOrCoDevelopmentCommitmentsRemunerated
|
0 | |
| CY2019Q1 | svra |
Contingent Milestones Or Co Development Commitments Accrued
ContingentMilestonesOrCoDevelopmentCommitmentsAccrued
|
0 | |
| CY2019Q1 | svra |
Prepaid Research And Development Tax Credit Receivable
PrepaidResearchAndDevelopmentTaxCreditReceivable
|
1236000 | |
| CY2018Q4 | svra |
Prepaid Research And Development Tax Credit Receivable
PrepaidResearchAndDevelopmentTaxCreditReceivable
|
1263000 | |
| CY2019Q1 | svra |
Prepaid Clinical Trial Costs
PrepaidClinicalTrialCosts
|
510000 | |
| CY2018Q4 | svra |
Prepaid Clinical Trial Costs
PrepaidClinicalTrialCosts
|
561000 | |
| CY2018Q1 | us-gaap |
Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
|
0 | |
| CY2017Q2 | svra |
Debt Instrument Prepayment Fee Percentage
DebtInstrumentPrepaymentFeePercentage
|
0.060 | |
| CY2019Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
400000 | |
| CY2019Q1 | svra |
Principal Payments Of Debt And End Of Term Charge Non Current
PrincipalPaymentsOfDebtAndEndOfTermChargeNonCurrent
|
25132000 | |
| CY2019Q1 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
243000 | |
| CY2018Q4 | us-gaap |
Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
|
0 | |
| CY2019Q1 | us-gaap |
Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
|
0 | |
| CY2018Q4 | us-gaap |
Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
|
0 | |
| CY2019Q1 | us-gaap |
Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
|
311000 | |
| CY2019Q1 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
212000 | |
| CY2019Q1 | us-gaap |
Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
|
0 | |
| CY2018Q4 | us-gaap |
Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
|
421000 | |
| CY2019Q1 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
121000 | |
| CY2018Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
162000 | |
| CY2019Q1 | svra |
Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
|
161000 | |
| CY2018Q4 | svra |
Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
|
107000 | |
| CY2019Q1 | svra |
Accrued Contracted Research And Development Costs
AccruedContractedResearchAndDevelopmentCosts
|
3580000 | |
| CY2018Q4 | svra |
Accrued Contracted Research And Development Costs
AccruedContractedResearchAndDevelopmentCosts
|
2044000 | |
| CY2019Q1 | svra |
Accrued General And Administrative Costs
AccruedGeneralAndAdministrativeCosts
|
368000 | |
| CY2018Q4 | svra |
Accrued General And Administrative Costs
AccruedGeneralAndAdministrativeCosts
|
371000 | |
| CY2019Q1 | svra |
Accrued Compensation
AccruedCompensation
|
392000 | |
| CY2018Q4 | svra |
Accrued Compensation
AccruedCompensation
|
643000 | |
| CY2019Q1 | svra |
Foreign Currency Exchange Derivative
ForeignCurrencyExchangeDerivative
|
85000 | |
| CY2018Q4 | svra |
Foreign Currency Exchange Derivative
ForeignCurrencyExchangeDerivative
|
26000 | |
| CY2019Q1 | us-gaap |
Deferred Revenue
DeferredRevenue
|
242000 | |
| CY2018Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
250000 | |
| CY2019Q1 | svra |
Accrued Lease Liability
AccruedLeaseLiability
|
709000 | |
| CY2019Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
41000 | |
| CY2018Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
41000 | |
| CY2019Q1 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
79490000 | |
| CY2018Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
86559000 | |
| CY2019Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
20000 | |
| CY2019Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
2000 | |
| CY2018Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
30000 | |
| CY2019Q1 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
79508000 | |
| CY2018Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
86529000 | |
| CY2019Q1 | us-gaap |
Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
|
0 | |
| CY2019Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | |
| CY2018 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | |
| CY2019Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
|
0 | |
| CY2018 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
|
0 | |
| CY2019Q1 | svra |
Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
|
201000000 | |
| CY2019Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
| CY2019Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2019Q1 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
4953454 | |
| CY2019Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
1676502 | |
| CY2017Q4 | svra |
Lease Commencement Date
LeaseCommencementDate
|
2018-01-01 | |
| CY2017Q4 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2021-07-31 | |
| CY2017Q4 | us-gaap |
Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
|
200000 | |
| CY2019Q1 | svra |
Lease Commencement Date
LeaseCommencementDate
|
2018-11-01 | |
| CY2019Q1 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2022-09-30 | |
| CY2019Q1 | us-gaap |
Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
|
100000 | |
| CY2019Q1 | svra |
Lease Rental Payments Percentage
LeaseRentalPaymentsPercentage
|
0.02 | |
| CY2017Q1 | svra |
Operating Lease Office Space
OperatingLeaseOfficeSpace
|
13707 | |
| CY2017Q1 | svra |
Lease Commencement Date
LeaseCommencementDate
|
2017-07-01 | |
| CY2017Q1 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2020-05-31 | |
| CY2017Q1 | svra |
Lease Agreement Date
LeaseAgreementDate
|
2014-06-19 | |
| CY2019Q1 | us-gaap |
Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
|
500000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
67000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1321000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
107000 | |
| CY2019Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1214000 | |
| CY2019Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
369000 | |
| CY2019Q1 | us-gaap |
Sublease Income
SubleaseIncome
|
153000 | |
| CY2019Q1 | us-gaap |
Lease Cost
LeaseCost
|
216000 | |
| CY2019Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
194000 | |
| CY2019Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P23M24D | |
| CY2019Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.085 | |
| CY2019Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1200000 | |
| CY2019Q1 | us-gaap |
Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
|
us-gaap:OtherAssetsNoncurrent | |
| CY2019Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
700000 | |
| CY2019Q1 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
us-gaap:AccruedLiabilitiesCurrent | |
| CY2019Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
500000 | |
| CY2019Q1 | us-gaap |
Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
|
us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent | |
| CY2019Q1 | svra |
Employment Agreement Description
EmploymentAgreementDescription
|
Upon termination without cause, and not as a result of death or disability or resignation for good reason, each of such officers is entitled to receive a payment of base salary for twelve months and a pro-rated portion of their unpaid bonus following termination of employment, and such officer will be entitled to continue to receive coverage under medical and dental benefit plans for twelve months or until such officer is covered under a separate plan from another employer. Upon a termination other than for cause or resignation for good reason within twelve months following a change in control, each of such officers is entitled to receive a payment of base salary for eighteen months and one-hundred percent of their unpaid bonus following termination of employment and such officer will be entitled to continue to receive coverage under medical and dental benefit plans for twelve months or until such officer is covered under a separate plan from another employer and will also be entitled to certain acceleration of such officer’s outstanding nonvested options at the time of such termination. | |
| CY2019Q1 | svra |
Percentage Of Unpaid Bonus To Be Paid Upon Termination
PercentageOfUnpaidBonusToBePaidUponTermination
|
1.00 | |
| CY2019Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1000000 | |
| CY2018Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
412000 | |
| CY2019Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4178454 | |
| CY2018Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3285851 | |
| CY2019Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-12112000 | |
| CY2018Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-26849000 | |
| CY2019Q1 | svra |
Undistributed Earnings And Net Income Loss Attributable To Common Stockholders Basic And Diluted
UndistributedEarningsAndNetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
|
-12112000 | |
| CY2018Q1 | svra |
Undistributed Earnings And Net Income Loss Attributable To Common Stockholders Basic And Diluted
UndistributedEarningsAndNetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
|
-26849000 |
